Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights
December 1, 9:06 AM
Gainers NexImmune (NASDAQ:NEXI) stock moved upwards by 343.1% to $10.99 during Friday’s pre-market session. The market value of…

ALT

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

GRI Bio Announces FDA Clearance Of IND For Lead Program GRI-0621, A Type 1 Invariant NKT Antagonist For The Treatment Of Idiopathic Pulmonary Fibrosis

By Benzinga Newsdesk
November 27, 9:37 AM
Clinical development plan leveraging 505(b)(2) regulatory pathwayInitiation of Phase 2a biomarker study on track to start before year endCurrently available treatments for IPF are limited to only two approved drugs that

GRI

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
November 23, 1:30 PM
Gainers Impel Pharmaceuticals (NASDAQ:IMPL) shares moved upwards by 141.4% to $0.77 during Thursday’s regular session. The market value…

AQB

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
November 15, 5:31 PM
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday’s after-market session. Today’s trading volume…

AUGX

Read More
1 minute read
  • Earnings
  • News

GRI Bio Had Cash And Cash Equivalents Of ~$3.5M, As Of September 30, 2023

By Benzinga Newsdesk
November 15, 9:26 AM
Summary of Financial Results for Third Quarter 2023Net loss was $11.0 million for the nine months ended September 30, 2023.Research and development expenses were $2.2 million and $0.2 million for the nine months ended

GRI

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
October 25, 5:31 PM
Gainers Clene (NASDAQ:CLNN) stock increased by 9.4% to $0.47 during Wednesday’s after-market session. The market value of their…

ACRX

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights
October 24, 5:31 PM
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock rose 30.2% to $0.27 during Tuesday’s after-market session. Today’s trading volume for this…

ACRX

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights
October 23, 5:31 PM
Gainers Unicycive Therapeutics (NASDAQ:UNCY) stock rose 7.8% to $0.87 during Monday’s after-market session. At the close, Unicycive Therapeutics’s…

AMRX

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
October 20, 5:31 PM
Gainers Apollomics (NASDAQ:APLM) stock increased by 23.6% to $2.15 during Friday’s after-market session. The company’s market cap stands…

APLM

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights
October 19, 5:31 PM
Gainers American Well (NYSE:AMWL) stock moved upwards by 22.9% to $1.16 during Thursday’s after-market session. American Well’s trading…

AMTI

Posts pagination

Previous 1 2 3 4 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service